The prostacyclin pathway in pulmonary arterial hypertension: a clinical review
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2017.1317599
Abstract: ABSTRACT Introduction: Prostacyclin is produced in vascular endothelial cells and acts via the IP prostacyclin receptor to cause vasodilation and inhibit smooth muscle cell proliferation and platelet aggregation. Prostacyclin production is reduced in pulmonary arterial… read more here.
Keywords: prostacyclin; prostacyclin pathway; arterial hypertension; pulmonary arterial ... See more keywords